Mary's Medicinals Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Mary's Medicinals's estimated annual revenue is currently $13.2M per year.
- Mary's Medicinals's estimated revenue per employee is $270,000
- Mary's Medicinals has 49 Employees.
- Mary's Medicinals grew their employee count by 17% last year.
- Mary's Medicinals currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Dixie Brands In...||$17.3M||64||10%||N/A|
|Warneke Paper B...||$11.1M||41||11%||N/A|
|Medicine Man Te...||$21.3M||79||46%||N/A|
What Is Mary's Medicinals?
Best known as the developer of the award-winning transdermal cannabis patch, Mary's Medicinals innovates at the intersection of technology and horticulture. Mary's is transforming how people view and utilize cannabis by developing accurately-dosed, natural pain-relief products that maximize the benefits of cannabinoids, terpenes and other plant nutrients for optimum patient care. Maryâ€™s Medicinals products are available throughout Arizona, Colorado, California, Illinois, Nevada, Oregon, Vermont and Washington. For more information, please visit www.marysmedicinals.com. Awards: 2017 Winner of Best Infused Product by National Cannabis Industry Association - Muscle Freeze 2016 Winner of Best Infused Product in Medical Advancements by The Cannabist - Muscle Freeze 2015 Winner of Most Innovative Product at the CannAwards - Transdermal Patch 2015 Stevie American Business Award for Best Health & Pharmaceuticals Product 2014 Invention of the Year in the Cannabis Business Awardskeywords:N/A
Number of Employees
Employee Growth %
|Craig Isenbart||Director Of Operations||Email Available|
|Elle Welch||Director of Marketing and Communications|
|Alexander Boyd||Manager, Finance & Accounting|
|Sam Hansen||Operations Manager||Email Available|
|Baker Brock||Office Manager|
|Alice O'Leary-Randall||Editor-in-chief, Mary's Medicinals Publications|
|Nicole Smith||Founder & CEO|
|Allie Greenstone||Brand Manager||Email Available|
|Eduardo Provencio||General Counsel|
|Brian Jansen||Chief Operating Officer (COO)|